# Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on “Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126”

**Authors:** Dragos Gabriel Iancu, Liviu Cristescu, Razvan Gheorghita Mares, Andreea Varga, Ioan Tilea

PMC · DOI: 10.3390/diagnostics16010056 · Diagnostics · 2025-12-23

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** CTEPH (MESH:D011655), PAH (MESH:D000081029)
- **Chemicals:** NTAR (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12785243/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12785243/full.md

---
Source: https://tomesphere.com/paper/PMC12785243